1. Home
  2. CMCL vs STXS Comparison

CMCL vs STXS Comparison

Compare CMCL & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caledonia Mining Corporation Plc

CMCL

Caledonia Mining Corporation Plc

N/A

Current Price

$22.15

Market Cap

552.3M

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.82

Market Cap

201.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMCL
STXS
Founded
1992
1990
Country
Jersey
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.3M
201.6M
IPO Year
2003
2004

Fundamental Metrics

Financial Performance
Metric
CMCL
STXS
Price
$22.15
$1.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$28.00
$4.00
AVG Volume (30 Days)
211.1K
421.3K
Earning Date
03-23-2026
03-09-2026
Dividend Yield
2.52%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
$38.38
$34.08
Revenue Next Year
N/A
$35.18
P/E Ratio
$10.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$1.54
52 Week High
$38.75
$3.59

Technical Indicators

Market Signals
Indicator
CMCL
STXS
Relative Strength Index (RSI) 35.11 34.89
Support Level $21.03 $1.74
Resistance Level $24.49 $2.52
Average True Range (ATR) 1.23 0.08
MACD -0.18 0.00
Stochastic Oscillator 21.31 8.51

Price Performance

Historical Comparison
CMCL
STXS

About CMCL Caledonia Mining Corporation Plc

Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: